SCHEMBL24835489

SCHEMBL24835489

CC(S)n1ncc2cnccc2c1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HASPIN Q8TF76 3/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
ROCK2 O75116 4/20 0.33
ROCK1 Q13464 4/20 0.33
KDM4C Q9H3R0 2/20 0.33
HDAC8 Q9BY41 1/20 0.33
KAT2B Q92831 2/20 0.33
PDE9A O76083 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
KDM4A O75164 1/20 0.32
KDM4B O94953 1/20 0.32
KDM5C P41229 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
KDM3A Q9Y4C1 1/20 0.32
GSK3B P49841 2/20 0.31
DYRK1A Q13627 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18237334 0.87 HASPIN (0.38) HASPINHTR2AHTR2CHTR2BROCK2
SCHEMBL19153953 0.75 KDM4C (0.41) HASPINROCK2ROCK1KDM4CKAT2B
SCHEMBL18237335 0.74 PDE9A (0.38) HTR2AHTR2CHTR2BKDM4CKAT2B
SCHEMBL26155648 0.71 CYP1A2 (0.40) HASPINADORA3ADORA2AADORA1KDM5A
SCHEMBL19153155 0.70 PDE9A (0.33) HASPINKDM4CHDAC8PDE9AKDM4A
SCHEMBL15341930 0.68 HTR2A (0.44) HTR2AHTR2CHTR2BROCK2ROCK1
SCHEMBL10072551 0.67 SMN1; SMN2 (0.51) PDE9AKDM4EALDH1A1LMNACYP1A2
SCHEMBL16339750 0.66 HDAC8 (0.47) HASPINHTR2AHTR2CHTR2BHDAC8
SCHEMBL20130533 0.66 NPC1 (0.43) KDM4EALDH1A1LMNACYP1A2CYP2C19
SCHEMBL4772542 0.65 BRD9 (0.44) HASPINHTR2AHTR2CHTR2BROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000993-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO INC (US) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230000993-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT HASPIN 1000/4885HTR2A 3908/4885HTR2C 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.